Yatharth Hospital & Trauma Care Services (YATHARTH) investor relations material

Executive summary

• Achieved record quarterly revenue of INR 3,205 million in Q3 FY26, up 46% year-over-year, and INR 8,577 million for 9M FY26, up 32% year-over-year.

• EBITDA for Q3 FY26 reached INR 742 million (+35% YoY), with adjusted margin at 29.2%; PAT grew 41% YoY to INR 431 million.

• New Delhi and Faridabad Sector 20 hospitals contributed INR 279 million, or 9% of group revenue, in their first full quarter.

• Agra Hospital (acquired Feb 2026, 150 operational beds expandable to 250) expected to contribute meaningfully to revenue and EBITDA from day one.

• Clinical excellence highlighted by advanced interventions and national awards for clinicians.

Financial highlights

• Q3 FY26 consolidated revenue: INR 3,205 million (+46% YoY); 9M FY26: INR 8,577 million (+32% YoY).

• Existing hospitals grew 33% YoY; new hospitals contributed 9% of revenue.

• Occupancy rate: 67% overall; Noida 91%, Greater Noida 74%, Noida Extension 61%, Jhansi Orchha 72%.

• ARPOB up 10% YoY to INR 33,744; Noida Extension ARPOB at INR 44,000, up 16% YoY.

• Net profit after tax: INR 431 million, up 41% YoY; PAT margin at 13.4%.

Outlook and guidance

• Q4 expected to surpass Q3 performance due to new hospital integration and ramp-up.

• Targeting 5,000-bed capacity in next 3-3.5 years, with operationalization over 4-5 years.

• Blended EBITDA margin guidance of 24%-25% over next 2-3 years due to ongoing expansion.

• ARPOB expected to grow at 10% YoY; oncology to reach 15% of specialty mix in 1.5 years.

• No material financial impact expected from new Labour Codes; wage structure aligned with regulations.